https://doi.org/10.4081/uij.2022.251
Continuing posterior tibial nerve stimulation after twelve weekly sessions: a randomized controlled trial
Submitted: 13 May 2020
Accepted: 16 November 2021
Published: 14 February 2022
Accepted: 16 November 2021
Abstract Views: 1995
PDF: 394
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Posterior Tibial Nerve Stimulation (PTNS) is a treatment option for refractory Overactive Bladder (OAB). There is currently no evidence to support which maintenance schedule is most effective. The objective of this study is to compare patientreported outcomes between monthly maintenance therapy and sessions scheduled Per patient request (PRN). We hypothesized that there is no difference in these measures between groups. After completing 12 sessions of PTNS, patients were randomized to monthly or PRN maintenance. Quality of life, patient satisfaction, and degree of symptom bother were assessed with validated questionnaires. Thirty six patients were randomized: 19 to monthly follow-up, and 17 to PRN follow-up. The PRN group demonstrated a significantly higher quality of life (p=0.04) with a large effect size (0.82). Over a three-month period, there was no significant difference in the average number of visits between the monthly and PRN groups, with an average of 1.79 (±1.18) and 1.24 (±1.35) visits, respectively (p=0.20). After six months of maintenance therapy, 42% of patients in the monthly group and 53% of patients in PRN group elected to continue therapy (p=0.27). There was no significant difference between the groups with regard to treatment satisfaction (p=0.62) or percent change in OAB symptoms (p=0.13). There is no difference between monthly and PRN follow-up in terms of patient satisfaction and symptom bother. However, the PRN group scored higher on the quality of life measure. PRN maintenance may optimize care for patients treating Overactive Bladder Syndrome with posterior tibial nerve stimulation.
Stewart F, Gameiro OL, El Dib R, et al. Electrical stimulation with non-implanted electrodes for overactive bladder in adults. Cochrane Database Syst Rev 2016;4:Cd010098.
DOI: https://doi.org/10.1002/14651858.CD010098.pub3
Shamliyan T, Wyman JF, Ramakrishnan R, et al. Benefits and harms of pharmacologic treatment for urinary incontinence in women: a systematic review. Ann Intern Med 2012;156:861-74, W301-10.
DOI: https://doi.org/10.7326/0003-4819-156-12-201206190-00436
Gormley EA, Lightner DJ, Faraday M, et al. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline amendment. J Urol 2015;193:1572-80.
DOI: https://doi.org/10.1016/j.juro.2015.01.087
Staskin DR, Peters KM, MacDiarmid S, et al. Percutaneous tibial nerve stimulation: a clinically and cost effective addition to the overactive bladder algorithm of care. Current Urol Rep 2012;13:327-34.
DOI: https://doi.org/10.1007/s11934-012-0274-9
Peters KM, Macdiarmid SA, Wooldridge LS, et al. Randomized trial of percutaneous tibial nerve stimulation versus extended-release tolterodine: results from the overactive bladder innovative therapy trial. J Urol 2009;182:1055-61.
DOI: https://doi.org/10.1016/j.juro.2009.05.045
Gaziev G, Topazio L, Iacovelli V, et al. Percutaneous Tibial Nerve Stimulation (PTNS) efficacy in the treatment of lower urinary tract dysfunctions: a systematic review. BMC Urol 2013;13:61.
DOI: https://doi.org/10.1186/1471-2490-13-61
van Leeuwen JH, Castro R, Busse M, et al. The placebo effect in the pharmacologic treatment of patients with lower urinary tract symptoms. Eur Urol 2006;50:440-52; discussion 453.
DOI: https://doi.org/10.1016/j.eururo.2006.05.014
Peters KM, Carrico DJ, MacDiarmid SA, et al. Sustained therapeutic effects of percutaneous tibial nerve stimulation: 24-month results of the STEP study. Neurourol Urodynamics 2013;32:24-9.
DOI: https://doi.org/10.1002/nau.22266
Lee HN, Chae JY, Lee HS, et al. Translation and linguistic validation of the Korean version of the treatment satisfaction visual analogue scale and the overactive bladder satisfaction with treatment questionnaire. Int Neurourol J 2017;21:309-19.
DOI: https://doi.org/10.5213/inj.1734992.496
Yalcin I, Bump RC. Validation of two global impression questionnaires for incontinence. Am J Obstet Gynecol 2003;189:98-101.
DOI: https://doi.org/10.1067/mob.2003.379
Coyne KS, Thompson CL, Lai JS, et al. An overactive bladder symptom and health-related quality of life short-form: validation of the OAB-q SF. Neurourol Urodyn 2015;34:255-63.
DOI: https://doi.org/10.1002/nau.22559
Arlandis S, Ruiz MA, Errando C, et al. Quality of life in patients with overactive bladder: validation and psychometric properties of the Spanish Overactive Bladder Questionnaire-short Form. Clinical Drug Invest 2012;32:523-32.
DOI: https://doi.org/10.1007/BF03261903
Stach-Lempinen B, Kujansuu E, Laippala P, et al. Visual analogue scale, urinary incontinence severity score and 15 D--psychometric testing of three different health-related quality-of-life instruments for urinary incontinent women. Scandinavian J Urol Nephrol 2001;35:476-83.
DOI: https://doi.org/10.1080/003655901753367587
Pleil AM, Coyne KS, Reese PR, et al. The validation of patient-rated global assessments of treatment benefit, satisfaction, and willingness to continue--the BSW. Value Health 2005;8 Suppl 1:S25-34.
DOI: https://doi.org/10.1111/j.1524-4733.2005.00069.x
Jimenez MA, Cambronero J. Validation of the Spanish version of the questionnaire <> in patients with overactive bladder. Actas Urologicas Espanolas 2013;37:473-9.
DOI: https://doi.org/10.1016/j.acuroe.2013.03.002
Homma Y, Yoshida M, Seki N, et al. Symptom assessment tool for overactive bladder syndrome--overactive bladder symptom score. Urology 2006;68:318-23.
DOI: https://doi.org/10.1016/j.urology.2006.02.042
Weinberg AC, Brandeis GH, Bruyere J, et al. Reliability and validity of the Overactive Bladder Symptom Score in Spanish (OABSS-S). Neurourol Urodynam 2012;31:664-8.
DOI: https://doi.org/10.1002/nau.21235
Peters KM, Carrico DJ, Perez-Marrero RA, et al. Randomized trial of percutaneous tibial nerve stimulation versus Sham efficacy in the treatment of overactive bladder syndrome: results from the SUmiT trial. J Urol 2010;183:1438-43.
DOI: https://doi.org/10.1016/j.juro.2009.12.036
Peters KM, Carrico DJ, Wooldridge LS, et al. Percutaneous tibial nerve stimulation for the long-term treatment of overactive bladder: 3-year results of the STEP study. J Urol 2013;189:2194-201.
DOI: https://doi.org/10.1016/j.juro.2012.11.175
Willis-Gray MG, Sandoval JS, Maynor J, et al. Barriers to urinary incontinence care seeking in White, Black, and Latina women. Female Pelvic Med Reconstruct Surg 2015;21:83-6.
DOI: https://doi.org/10.1097/SPV.0000000000000100
Thom DH, van den Eeden SK, Ragins AI, et al. Differences in prevalence of urinary incontinence by race/ethnicity. J Urol 2006;175:259-64.
DOI: https://doi.org/10.1097/00005392-200601000-00092
How to Cite
Zigman, J. S., Handler, S. J., Amaya, S., Zeno, A. O., Takashima, Y., Navas, J. J., & Yazdany, T. (2022). Continuing posterior tibial nerve stimulation after twelve weekly sessions: a randomized controlled trial. Urogynaecologia, 34(1). https://doi.org/10.4081/uij.2022.251
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
An Open Access Publication is one that meets the following two conditions:
- the author(s) and copyright holder(s) grant(s) to all users a free, irrevocable, worldwide, perpetual right of access to, and a license to copy, use, distribute, transmit and display the work publicly and to make and distribute derivative works, in any digital medium for any responsible purpose, subject to proper attribution of authorship, as well as the right to make small numbers of printed copies for their personal use.
- a complete version of the work and all supplemental materials, including a copy of the permission as stated above, in a suitable standard electronic format is deposited immediately upon initial publication in at least one online repository that is supported by an academic institution, scholarly society, government agency, or other well-established organization that seeks to enable open access, unrestricted distribution, interoperability, and long-term archiving.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
Similar Articles
- Barbara Cristina Gentile, Roberto Giulianelli, Luca Albanesi, Gabriella Mirabile, Francesco Pisanti, Transobturator tension-free vaginal tape is the most common procedure in women with stress urinary incontinence: our experience , Urogynaecologia: Vol. 28 No. 1 (2014)
- F. BERNASCONI, M. GRASSO, C. MANTOVANI, E. LUCCHINI, S. ARIENTI, C. CERRI, SOCIAL COST OF FEMALE URINARY INCONTINENCE: EPIDEMIOLOGY, COST OF ILLNESS AND COST/EFFECTIVENESS ANALYSIS , Urogynaecologia: Vol. 17 No. 1 (2003)
- M. Tamburello, V. Farruggia, S.M. Rubino, TWO CASES OF BLADDER PROLENE® TAPE EXPOSURE AFTER TVT PROCEDURE , Urogynaecologia: Vol. 16 No. 1 (2002)
- Vito Leanza, Eva Intagliata, Gianluca Leanza, Rosario Vecchio, Pelvic posterior compartment defects: comparative study of two vaginal surgical procedures , Urogynaecologia: Vol. 27 No. 1 (2013)
- Julián Oñate Celdrán, Francisco M. Gonzalez Valverde, After Cesarean vesicouterine fistula (Youssef Syndrome) with successful conservative management , Urogynaecologia: Vol. 30 No. 1 (2017)
- F. Mantovani, A. Del Nero, S. Confalonieri, E. Pisani, COLLAGEN FOR U.I. MINIMAL DOSE INJECTIONS IN SCHEDULED STEPS TO IMPROVE CLINICAL RESULTS , Urogynaecologia: Vol. 16 No. 1 (2002)
- A. Albiero, A. Gazzoni, S. Giudici, S. Poggi, L. Fedele, EVALUATION OF EFFICACY OF DIFFERENT SURGICAL PROCEDURES IN THE TREATMENT OF SUI AND GENITAL PROLAPSE , Urogynaecologia: Vol. 15 No. 3 (2001)
- Pau Sarrio-Sanz, Ana Isabel Lopez-Lopez, Laura Martinez-Cayuelas, Luis Gomez-Perez, Manuel Angel Ortiz-Gorraiz, Jesús Romero-Maroto, Is pelvic organ prolapse correction with vaginal mesh suitable with a correct indication and protocolized follow-up? , Urogynaecologia: Vol. 34 No. 1 (2022)
- A. Cianci, S. Caruso, S. Bandiera, M.G. Matarazzo, F. Rapisarda, G. Gangarossa, S. Cianci, R. Giordano, L. Rampello, ELECTROMYOGRAPHY OF THE URETHRAL SPHINCTER IN SUI , Urogynaecologia: Vol. 23 No. 3 (2009)
- S. Dati, V. De Lellis, P. Palermo, G. Carta, A COMPARISON BETWEEN SYNTHETIC AND BIOSYNTHETIC MESHES IN THE SURGICAL TREATMENT OF SEVERE GENITAL PROLAPSE: RESULTS AND COMPLICATIONS , Urogynaecologia: Vol. 23 No. 3 (2009)
You may also start an advanced similarity search for this article.